Litiasis Renal

Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters in patients with lithiasis

Devicare and nine leading Spanish hospitals in urology have successfully completed the clinical trial which demonstrates the efficacy of the combined use of a medical device (Lit-Control® pH Meter) and a nutraceutical (Lit-Control® pH Down) to prevent the encrustation of double J catheters by monitoring urinary pH and supplying phytates (crystallisation inhibitors).

The results of this […]

Dr Carlos Torrecilla: “We have the solution to prevent the encrustation of double J catheters”

Interview

December 12, 2018

Dr Carlos Torrecilla, director of the Lithiasis Unit of the Bellvitge University Hospital and national coordinator of the Lithiasis and Endourology Group of the Spanish Association of Urology, is the principal investigator of a clinical trial sponsored by Devicare conducted in nine Spanish university hospitals (Bellvitge, La Paz, Río Hortega, Puigvert Foundation, San […]

Devicare and Exeltis signed an agreement to market the Lit-Control in Spain

The multinational company Exeltis and the digital therapeutics company Devicare have signed an agreement to market the Lit-Control® family of products in Spain. Lit-Control® is the world’s first digital therapeutics solution that allows the most common urological diseases to be prevented and treated effectively from home while also improving patients’ adherence to the treatment.

This collaboration […]

Devicare launches e-commerce site for Lit-Control® in Spain

Improving your urinary health is now easier thanks to the new website Lit-control.es. The e-commerce site, designed by Devicare’s digital marketing department, is completely patient-focused: detailed information on Lit-Control® products to monitor urinary pH levels, online purchases and a private area with different functionalities that provide improved know-how and patient empowerment in the management of […]

Devicare continues its expansion in Latin America

Devicare is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.

At the end of […]

New treatments for kidney stones presented in the National Urology Congress

The LXXXIII National Urology Congress, which brought together more than one thousand urologists from 13 to 16 June in Gijón, focused its debate on different advances as a medical solution which will improve the diagnosis and treatment of lithiasis. Lithiasis (renal calculi or kidney stones) affects 10% of the Spanish population and this figure continues […]

A study published in ‘Journal of Endourology’ certifies that Lit-Control® is the best method to control urinary pH

A team of urologists from the Paris-Sorbonne University, the Tenon University Hospital, the AZ Klina Hospital and the University Hospital of Zurich has analysed the portable urinary pH control methods and has certified that the Lit-Control® pH Meter by Devicare is the best on the market.

The research, published in the Journal of Endourology, has compared the Lit-Control® pH Meter device designed for home use with other methods. Lit-Control® pH Meter […]

The first Lit-Control® units are now on sale in pharmacies in France

Lit-Control® by Devicare, the medical solution to prevent and treat recurring urological diseases which represent the second most common cause of primary care consultations1, has been on sale now for a few weeks in France.

The novel aspect of Lit-Control® is that it allows patients to measure their own urinary pH with the support of remote […]

Devicare and Premier Medical close an agreement to distribute Lit-Control in Ireland

Devicare and Premier Medical Ltd have signed an agreement to market the Lit-Control® family of products in Ireland intended to reduce the recurrence of chronic urological diseases (renal and urinary lithiasis, urine infections, calcification of double J stent catheters, etc…). Every year 50,000 cases of lithiasis are diagnosed in Ireland and it is estimated that […]

Devicare promotes a pioneering clinical trial to prevent the calcification of double J stent catheters

Devicare and nine leading hospitals in urology have started the pioneering international “Double J” study to evaluate the combined use of a medical device and a nutraceutical in controlling urinary pH and inhibiting crystallisation in order to prevent the calcification of double J stent catheters and reduce the number of associated complications.

“The calcification of a […]